Active ETFs continue to rise in significance for investors, with flows on track for another record amid more and more launches. Amid that rise for the category, certain ETFs have stood out of late, the T. Rowe Price Health Care ETF (TMED) included. The fund is not only performing well in the last month, but also sending a buy signal according to its buy chart. See more: Investing in Biotech? Look to Active for Index Performance Dispersion TMED charges a 44 basis point fee to actively invest in healthcare st ...